1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Epiomic Epidemiology Series: Ovarian Cancer Forecast in 17 Major Markets 2015-2025

Epiomic Epidemiology Series: Ovarian Cancer Forecast in 17 Major Markets 2015-2025

  • September 2015
  • -
  • Black Swan Analysis Ltd132
  • -
  • 50 pages

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Ovarian Cancer in 17 Major Markets

Ovarian Cancer begins in the ovaries, resulting from abnormal cells that have the ability to spread to other parts of the reproductive system and, in advanced stages, other parts of the body. The cause for Ovarian Cancer is not currently known, most DNA mutations for ovarian cancer are acquired genetic changes, however a link still has not yet been found to any environmental factors that may cause the mutation. This report provides the current incidence population for Ovarian Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Australia, Canada, Mexico, Turkey, South Africa, Saudi Arabia, Argentina and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, grades and associated Charlson Co-morbidity scoring of Ovarian Cancer. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Ovarian Cancer have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Ovarian Cancer include:

-Diabetes
-Myocardial Infarct
-Mild Liver Disease
-Congestive Heart Failure
-Dementia

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Ovarian Cancer’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Ovarian Cancer and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on Ovarian Cancer’s prevalent population.
-Identify sub-populations within Ovarian Cancer which require treatment.
-Gain an understanding of the specific markets that have the largest number of Ovarian Cancer patients.

Table Of Contents

Epiomic Epidemiology Series: Ovarian Cancer Forecast in 17 Major Markets 2015-2025
Ovarian Cancer
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Co-morbid Conditions Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Ovarian Cancer Incidence
-Stages and Grading of Ovarian Cancer
o FIGO Staging of Ovarian Cancer
o Charlson Co-Morbidity Index and Ovarian Cancer
o Histopathology of Tumour Cells in Ovarian Cancer
-Abbreviations and Acronyms used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix

List of Figures
-Ovarian Cancer Incidence Rates for 2015
List of Tables
-AJCC Tumour Grading Classification for Ovarian Cancer
-FIGO Stage Descriptors of Ovarian Cancer
-Charleston Co-morbidity Scoring Classification of Ovarian Cancer
-Incidence of Ovarian Cancer, females (000s)
-AJCC Stage at diagnosis for Ovarian cancer patients, females (000s)
-FIGO staging in Ovarian Cancer patients, females (000s)
-Stage I FIGO subtypes in Ovarian Cancer patients, females (000s)
-Stage II FIGO subtypes in Ovarian Cancer patients, females (000s)
-Stage III FIGO subtypes in Ovarian Cancer patients, females (000s)
-Charleston Co-morbidity Scores for Ovarian Cancer patients, females (000s)
-Major histopathological type in Ovarian Cancer patients, females (000s)
-Adenocarcinoma subtypes in Ovarian Cancer patients, females (000s)
-Abbreviations and Acronyms used in the Report
-USA Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-France Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Germany Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Italy Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Spain Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-United Kingdom Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Brazil Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Japan Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-India Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Australia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Canada Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Mexico Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Turkey Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-South Africa Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Saudi Arabia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Argentina Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)
-Russia Incidence of Ovarian Cancer by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Ovarian Cancer: Analytical Tool

Ovarian Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

Women’s Health Diagnostics Market by Application End User - Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) ...

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • September 2016
  • by Global Data

Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the US

  • November 2016
    8 pages
  • Cancer  

  • United States  

View report >

Cancer Statistics in the UK

  • November 2016
    20 pages
  • Cancer  

    Blood Transfusi...  

  • United Kingdom  

    United States  

View report >

Related Market Segments :

Ovarian Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.